Top CMOS in Europe 2021

We are pleased to announce that Pharma Tech Outlook has recognized SONEAS Chemicals Ltd. as a top 10 CMO in Europe for 2021.

 

 

Soneas Research merged into Soneas Chemicals Ltd

IMPORTANT : Soneas Research Ltd merged into Soneas Chemicals Ltd

We are pleased to notify all the concerned parties that we are happy to announce that due to the Company’s corporate structure change, the Soneas Research Limited will merge into the Soneas Chemicals Limited (its sole owner) which will be effective from 31st October 2020. In order to implement this change, all the contracts will be taken over by Soneas Chemicals Limited.
If you have any questions, feel free to contact us at sales@soneas.com.

Click  here to read the full document : Merger document

 

CHEMISTRY TODAY 4/2020

Read the latest views of Mr Jozsef Repasi, Managing director of SONEAS Chemicals & Research, in CHEMICA OGGI- Chemistry Today’s July/August publication.  Mr. Repasi has described the market trends during this pandemic and the strategies to make sure smooth continuity of business. Additionally, you can also read about our target markets, relevant key success factors  and the key changes over last decade.

To read full article, follow this link:

https://www.teknoscienze.com/Contents/Riviste/Sfogliatore/CO4_2020/50/

The Chemical Revolution of Central Europe

 Mr Jozsef Repasi, Maging director of SONEAS Chemicals & Research, talking about the chemical revolution of central Europe in “American Chemical Society’s” latest publication.

Read more: https://www.linkedin.com/feed/update/urn:li:activity:6622788636037402625

MBA Students’ visit from San Francisco University

This autumn József Répási have met with MBA students from University of San Francisco. During the meeting Mr. Répási talked about the new stragegy of the company and his opinion about the appropriate attitude of everyday work to meet the challenges and reach our goals. The meeting was closed with a guided site tour and personal discussion with Mr Répási.

Their message:

“Hello,

Thank you again for taking the time to chat with us and giving such a thought-provoking presentation. I am ordering a copy of “Antifragile” from Amazon to read on my Kindle on the way to Bilbao on Friday!

And here is the photo we took today.
Cheers!”

Interview Jozsef Repasi – Managing Director, Soneas, Hungary

Soneas MD Jozsef Repasi discusses the shift back towards Central and Eastern Europe for contract manufacturing services, the company’s growth since separating from Ubichem, and his ambitions for Soneas to become a fully integrated, end-to-end service provider.

 

http://pharmaboardroom.com/interviews/interview-jozsef-repasi-managing-director-soneas-hungary/

 

MBA students’ visit from Montclair State University

MBA students from Montclair State University (Montclair, NJ, USA) have visited Soneas Research Ltd (Budapest, Hungary) at its Berlini site in 05-23-2016. During the event the Founder and Managing Direct of Soneas Research Ltd (formally Ubichem Research Ltd) József Répásai, held a lecture about the history of the company, its present and future opportunities and challenges at the European and Global market as a successful R&D and chemical manufacturer service provider. The lecture was followed by a guided tour at the R&D facility and a free question and answer session with Mr. Répási.

Mr. Répási is always looking for opportunities to educate students from wide area of sciences and his lectures are informative and stimulating, where free discussion is always welcome.

We received several feedbacks from the attendance so far. See the latest ones below.

“Dr. Repasi is a very passionate and inspiring speaker. Many students were impressed and inspired by his speech.  He loves what he is doing and is not afraid of challenges. Both the presentation and the lab visit were very well prepared. The research director, who did his post-doc study in USC, led the lab visit, and it was great.”

“The speaker was excellent and passionate about his company and research. The meeting and facility tour were set up nicely. Plenty of snacks and refreshments were provided for us.”

ChemSpec Europe, Basel, Switzerland – June 1-2, 2016

Chemspec Europe 2016 is the international exhibition for fine and speciality chemicals. For purchasers and agents looking for specific products or bespoke solutions, the event is the ideal marketplace to meet with manufacturers, suppliers and distributors of fine and speciality chemicals. With its dedicated exhibition profile Chemspec Europe is the place to be for international industry professionals.

Beside exhibition stands of leading manufacturers and distributors from all over the world, visitors will be able to attend a series of top-class conferences and workshops. The free conferences provide first-hand research results; numerous networking opportunities foster exchange with industry experts.

The 31st edition of this highly successful industry event will take place from 1–2 June 2016 in one of Europe’s major hubs for the fine and speciality chemicals industry. The Basel region borders three of Europe’s strongest countries in the chemical sector – Germany, France and Switzerland – and is therefore the ideal exhibition venue.

Establish new business contacts, benefit from excellent networking opportunities and be inspired by the latest results in R&D at top-class conferences and workshops. Be part of the show where ideas become innovations!

Partner Collaborations Advance Second-Generation Elevance Biorefinery Technology

Woodridge, Illinois, USA (Jan. 19, 2016) – In collaboration with several partners, including the special contribution of Versalis under a strategic partnership started in early 2014, Elevance Renewable Sciences, Inc. — a high-growth company that creates novel specialty chemicals from natural oils — has successfully completed scale-up of a second-generation biorefinery technology of the company’s olefin metathesis technology, utilizing ethylene and natural oil feedstocks.

The ethenolysis process advancement represents an important milestone for the development of a second-generation metathesis technology — the first of its kind — enabling an enhanced product portfolio from natural oils metathesis.

Catalysts produced by XiMo AG were used at Soneas’ manufacturing facility in Budapest, Hungary. The run represented a scale up of 40,000 times what had been previously demonstrated in the laboratory and the largest ever usage of “Schrock” (Molybdenum/Tungsten) catalysts for metathesis with ethylene and a renewable oil.

“This significant accomplishment advances the interests of several of our partners and demonstrates the advantages of working together,” said Mel Luetkens, COO at Elevance. “Elevance is pleased to be at the center of this collaboration and to be advancing these important developments for our partners and us. It is another validation of Elevance’s technology and the value that we bring to our partner relationships.”

XiMo AG, a company focused on the development and application of proprietary metathesis catalysts, and Elevance began working together in January 2011, carrying out successful demonstrations that make the Molybdenum- and Tungsten- catalyzed metathesis of natural oil esters commercially competitive. Soneas, formerly known as Ubichem Pharma Manufacturing, is a professional chemical service provider with pilot and commercial scale manufacturing facilities.

The advancement was partially funded by and supports a wider strategic partnership between Versalis, the chemical subsidiary of Eni, and Elevance that includes the joint development of Elevance’s ethenolysis technology. This takes advantage of Versalis’ extensive skills in catalysis process development and engineering design and Elevance’s proprietary know-how regarding metathesis and associated engineering with the use of vegetable oils in producing specialty chemicals for premium applications. Meanwhile, Versalis and Elevance have also been collaborating for the implementation at the Versalis Porto Marghera site of a biorefinery based on Elevance proprietary technology of natural oils’ metathesis with 1-butene.

“We strongly believe in the potential of metathesis technology since it is a mild reaction that does not destroy the molecular complexity of vegetable feedstocks, the highest value of them,” said Sergio Lombardini, Director of Research & Innovation Technology at Versalis. “This is why even in the engineering phase for a butene-1 metathesis plant, we are looking at ethylene as an alternative co-feedstock aiming to target an even higher value of products portfolio.”

The ethenolysis tolling run was also partially funded by a grant from the United States Soybean Board given to Elevance for metathesis of soybean oil products, which were used as feedstocks for this project.

About Elevance Renewable Sciences, Inc.

Headquartered in Woodridge, Illinois, USA, Elevance Renewable Sciences, Inc. is a high-growth company that creates novel specialty chemicals that perform better from renewable feedstocks, making the products that industry and consumers use every day better. Using a proprietary technology called olefin metathesis, the company delivers specialty chemicals that exceed the performance of existing products while leaving a smaller environmental footprint — for use in personal care products, detergents and cleaners, engineered polymers, lubricants and additives, and other specialty chemicals markets. To learn more, visit www.elevance.com or www.renewicals.com

About Versalis

Versalis (Eni) is interfacing with markets through globally-oriented strategies and a market-driven product portfolio. It leads the industry in manufacturing intermediates, polyethylene, styrenics and elastomers and has entered the green chemicals and polymers industry partnering also with worldwide biotech companies. Versalis prides itself on its wide range of proprietary technologies, wide-reaching distribution network and after-sales assistance. As part of its new strategy, the company aims to gain a leadership position in fast-growing markets by leveraging its technological and industrial expertise. In Asia, Versalis has entered into partnerships with global petrochemical producers for development of its elastomer division. To learn more, visit www.versalis.eni.com.

About XiMo AG

XiMo is a Swiss-based company focused on the development and application of proprietary metathesis catalysts for use in the specialty chemical, agro chemical, renewables, pharmaceutical, flavors and fragrances, polymers and advanced materials sectors. The company’s molybdenum and tungsten catalysts are based on the breakthrough scientific research of founders Amir Hoveyda at Boston College and Richard Schrock at MIT, co-winner of the 2005 Nobel Prize in Chemistry. XiMo partners with selected leading companies on a time-limited exclusive basis, providing access to its intellectual property and technical expertise, to solve important industrial chemistry problems and to enable development of novel molecules and materials. XiMo’s complexes deliver both high activity and selectivity in metathesis transformations, enabling efficient Z-selective cross-metathesis, as well as enantioselective reactions. Details are available on XiMo’s website: www.ximo-inc.com.

About Soneas

Headquartered in Budapest, Hungary, Soneas is a chemical service provider with a pragmatic approach to innovation. Providing a comprehensive range of chemistry services. Developing and producing starting materials, intermediates and fine and specialty chemicals for pharma and non-pharma applications from 100s of grammes up to a 100 tonnes. As a committed chemical expert, having 20 years of experience in R&D, Soneas works to a high degree of accuracy and reliability. Having a comprehensive range of chemistry services (from lab through pilot to commercial scale), to support development and manufacturing activities. To learn more, visit www.soneas.com.

Request a call!

 

Thank you for your interest in Ubichem's solutions. Please, complete and submit this form, and one of our specialists will contact you shortly.